Interleukin-6 expression after renal transplantation

Nephrology Dialysis Transplantation

Volumn 12, Issue 4, 1997, Pages 753-759

  Waiser, J ^a   Budde, K ^a   Katalinic, A ^b   Kuerzdorfer M ^b   Riess R ^c   Neumayer, H H ^a  

^a CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

^b UNIVERSITY OF ERLANGEN NUREMBERG   (Germany)

^c KLINIKUM NÜRNBERG   (Germany)

Author keywords

IL 6; IL 6 soluble receptor; Kidney transplantation; Rejection; Renal transplantation

Indexed keywords

INTERLEUKIN 6; INTERLEUKIN 6 RECEPTOR; THYMOCYTE ANTIBODY;

ACUTE KIDNEY TUBULE NECROSIS; ARTICLE; BIOASSAY; BLOOD LEVEL; CELL LINE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; INFECTION; KIDNEY BIOPSY; KIDNEY GRAFT REJECTION; KIDNEY TRANSPLANTATION; MAJOR CLINICAL STUDY; MONONUCLEAR CELL; PRIORITY JOURNAL; URINE LEVEL;

ACUTE DISEASE; ANTIGENS, CD; CHRONIC DISEASE; GRAFT REJECTION; GRAFT SURVIVAL; HUMANS; IMMUNOHISTOCHEMISTRY; INTERLEUKIN-6; KIDNEY; KIDNEY TRANSPLANTATION; RECEPTORS, INTERLEUKIN; RECEPTORS, INTERLEUKIN-6; TIME FACTORS;

EID: 0030934551     PISSN: 09310509     EISSN: None     Source Type: Journal    
DOI: 10.1093/ndt/12.4.753     Document Type: Article

References (36)

1. Thorogood J, Van Houwelingen JC, Van Rood JJ, Zantvoort FA, Schreuder GMT, Persijn GG. Factors contributing to long-term kidney graft survival in Eurotransplant. Transplantation 1992; 54: 152-158
2. Matas AJ, Gillingham KJ, Payne WD, Najarian JS. The impact of an acute rejection episode on long-term renal allograft survival. Transplantation 1994; 57: 857-859
3. Dennis MJ, Foster MC, Ryan JJ, Burden RP, Morgan AG, Blarney RW. The increasing importance of chronic rejection as a cause of renal allograft failure. Transplant Int 1989; 2: 214-217
4. Hirano T, Akira S, Taga T, Kishimoto T. Biological and clinical aspects of interleukin 6. Immunology Today 1990; 1: 443-449
5. Ruef C, Budde K, Lacy J et al. Interleukin 6 is an autocrine growth factor for mesangial cells. Kidney Int 1990; 38: 249-257
6. Fukatsu A, Matsuo S, Yuzawa Y, Miyai H, Futenma A, Kato K. Expression of interleukin 6 and major histocompatibility complex molecules in tubular epithelial cells of diseased human kidneys. Lab Invest 1993; 69: 58-67
7. Ray A, Sehgal PB. Cytokines and their receptors: molecular mechanisms of interleukin-6 gene repression by glucocorticoids. J Am Soc Nephrol 1992; 2: 214-221
8. Yoshimura N, Kahan BD, Oka T. The in vivo effect of cyclosporine on interleukin-6 gene expression in renal transplant patients. Transplant Proc 1991; 23: 958-960
9. Vandenbroecke C, Caillat-Zucman S, Legendre C et al. Differential in situ expression of cytokines in renal allograft rejection. Transplantation 1991; 51: 602-609
10. Tovey MG, Deglise-Favre A, Schoevaert D. Differential in situ expression of cytokine genes in human renal transplantation. Kidney Int 1993; 43 [Suppl 39]: S129-S132
11. Krams SM, Falco DA, Villanueva JJC et al. Cytokine and T cell receptor gene expression at the site of allograft rejection. Transplantation 1992; 53: 151-156
12. Hancock WH, Whitley WD, Tullius SG et al. Cytokines, adhesion molecules, and the pathogenesis of chronic rejection of rat renal allografts. Transplantation 1993; 56: 643-650
13. Fukatsu A, Matsuo S, Tamai H, Sakamoto N, Matsuda T, Hirano T. Distribution of interleukin-6 in normal and diseased human kidney. Lab Invest 1991; 65: 61-66
14. Raasveld MHM, Weening JJ, Kerst JM, Surachno S, ten Berge RJM. Local production of interleukin-6 during acute rejection in human renal allografts. Nephrol Dial Transplant 1993; 8: 75-78
15. Yoshimura N, Oka T, Kahan BD. Sequential determinations of serum interleukin 6 levels as an immunodiagnostic tool to differentiate rejection from nephrotoxicity in renal allograft recipients. Transplantation 1991; 51: 172-176
16. Daniel V, Pasker S, Reiss U et al. Plasma GM-CSF, IL-6, and IL-3 monitoring allows differentation between infection and rejection in some renal transplant recipients: preliminary results of a retrospective study. Transplant Proc 1993; 25: 893-896
17. Kutukculer N, Clark K, Rigg KM et al. The value of posttransplant monitoring of interleukin (IL)-2, IL-3, IL-6, IL-8, and soluble CD23 in the plasma of renal allograft recipients. Transplantation 1995; 59: 333-340
18. Van Oers MHJ, van der Heyden AAPAM, Aarden LA. Interleukin 6 (IL-6) in serum and urine of renal transplant recipients. Clin Exp Immunol 1988; 71: 314-319
19. Raasveld MHM, Bloemena E, Wilmink JM, Surachno S, Schellekens PTA, ten Berge RJM. Interleukin-6 and neopterin in renal transplant recipients: a longitudinal study. Transplant Int 1993; 6: 89-94
20. Bloemena E, Ten Berge IJM, Surachno J, Wilmink JM. Kinetics of interleukin 6 during OKT3 treatment in renal allograft recipients. Transplantation 1990; 50: 330-331
21. Newstead GN, Lamb WR, Brenchley PEC, Short CD. Serum and urine IL-6 and TNF-α in renal transplant recipients with graft dysfunction. Transplantation 1993; 56: 831-835
22. Dinarello C. Cytokines: Agents provocateurs in hemodialysis? Kidney Int 1992; 41: 1-12
23. Solez K, Axelsen RA, Benediktsson H et al. International standardization of criteria for the histologic diagnosis of renal allograft rejection: the Banff working classification of kidney transplant pathology. Kidney Int 1993; 44: 411-422
24. Aarden LA, de Groot ER, Schaap OL, Lansdorp PM. Production of hybridoma growth factor by human monocytes. Eur J Immunol 1987; 17: 1411-1416
25. Mosmann TR. Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assays. J Immunol Meth 1983; 65: 55-63
26. May LT, Patel K, Garcia D et al. Sustained high levels of circulating chaperoned interleukin- 6 after active specific cancer immunotherapy. Blood 1994; 84: 1887-1895
27. May LT, Neta R, Moldawer LL, Kenney JS, Patel K, Sehgal PB. Antibodies chaperone circulating IL-6. J Immunol 1993; 151: 3225-3236
28. May LT, Viguet H, Kenney JS, Ida N, Allison AC, Sehgal PB. High levels of complexed interleukin-6 in human blood. J Biol Chem 1992; 267: 19698-19704
29. Ohta K, Takano N, Seno A et al. detection and clinical usefulness of urinary interleukin-6 in the diseases of the kidney and the urinary tract. Clin Nephrol 1992; 4: 185-189
30. Taga T, Hibi M, Hirata Y et al. Interleukin-6 triggers the association of its receptor with a possible signal transducer, gp130. Cell 1989; 58: 573-581
31. Taga T, Kishimoto T. Cytokine receptors and signal transduction. FASEB J 1992; 6: 3387-3396
32. Müllberg J, Schooltink H, Toyan T et al. The soluble interleukin-6 receptor is generated by shedding. Eur J Immunol 1993; 23: 473-480
33. Novick D, Engelmann H, Wallach D, Rubinstein M. Soluble cytokine receptors are present in normal human urine. J Exp Med 1989; 170: 1409-1414
34. Honda M, Yamamoto S, Cheng M et al. Human soluble IL-6 receptor: its detection and enhanced release by HIV infection. J Immunol 1992; 148: 2175-2180
35. Merville P, Pouteil-Noble C, Wijdenes J, Potaux L, Touraine JL, Banchereau J. Cells infiltrating rejected human kidney allografts secrete IFN-gamma, IL-6, and IL-10, and are modulated by IL-2 and IL-4. Transplant Proc 1993; 25: 111-113
36. Leimenstoll G, Engemann R, Gassel J et al. Cytokine secretion capacity of mononuclear cells in renal transplant recipients: the effect of two different dose schedules. Transplant Proc 1993; 25: 2666-2668